Cargando…
The K167I variant of DNA polymerase β that is found in Esophageal Carcinoma patients impairs polymerase activity and BER
DNA polymerase β (pol β) is a key enzyme in DNA base excision repair, and an important factor for maintaining genomic integrity and stability. Esophageal carcinoma (EC) patients who have been identified as carrying the K167I variant of pol β have been shown to have decreased life expectancy. However...
Autores principales: | Wang, Yuanyuan, Zang, Wenqiao, Du, Yuwen, Chen, Xiaonan, Zhao, Guoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630582/ https://www.ncbi.nlm.nih.gov/pubmed/26527528 http://dx.doi.org/10.1038/srep15986 |
Ejemplares similares
-
Overexpression of A613T and G462T variants of DNA polymerase β weakens chemotherapy sensitivity in esophageal cancer cell lines
por: Wang, Yuanyuan, et al.
Publicado: (2016) -
Retraction Note: Overexpression of A613T and G462T variants of DNA polymerase β weakens chemotherapy sensitivity in esophageal cancer cell lines
por: Wang, Yuanyuan, et al.
Publicado: (2019) -
MiR‐149 sensitizes esophageal cancer cell lines to cisplatin by targeting DNA polymerase β
por: Wang, Yuanyuan, et al.
Publicado: (2018) -
Abundance of BER-related proteins depends on cell proliferation status and the presence of DNA polymerase β
por: Yamamoto, Mizuki, et al.
Publicado: (2015) -
Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo
por: Wang, Lei, et al.
Publicado: (2014)